Psychosocial functioning in adults with PKU
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) are doing socially and emotionally. They will ask you and a relative who lives with you to answer questionnaires about daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and under 59 years old.
- You have PKU (phenylketonuria) or HMP (hyperphenylalaninemia) and are being followed by a doctor.
- You live with a relative who is also willing to take part (they must be 18 or older).
- You agree to let the study use your data and have no objection to participating.
- You have health insurance (social security) in France.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
This study looks at how the brain ages in adults with PKU. It uses an MRI scan to compare brain changes between people with PKU and healthy volunteers.
This study tests a new injection called GS1168 for adults with phenylketonuria (PKU) whose current treatments are not working well. The goal is to see if it can help control their PKU better.
This study tests a new microtablet form of protein substitute for people with PKU. It aims to see if taking these tablets helps you meet your protein needs while staying on your PKU diet.
This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.
Hear when a new Phenylketonuria (PKU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.